Indeed, in pre-clinical models, retatrutide, a triple agonist (GLP-1/GIP/glucagon), resulted in greater WL and improved glucose profile compared to tirzepatide through increased energy expenditure and reduced calorie intake [80, 81]
However, consulting a doctor is very important in case of severe or persistent side effects
For a 220-pound person, that's roughly 11-18 pounds
eating more minimally processed foods higher in nutrients, fiber, and/or protein
GLP-1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF-B signaling pathways in streptozotocin-induced diabetic rats
When you take a GLP-1 medication like semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda), it: Slows down how quickly food leaves your stomach, which keeps you feeling full for longer Signals to your brain that youre satisfied, reducing those constant thoughts about food and snacking Helps your pancreas release the right amount of insulin when your blood sugar rises These medications were initially developed for type 2 diabetes, which is why you might have heard of Ozempic being used off-label for weight loss